These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 28677206)

  • 21. Imiquimod induced ApoE-deficient mice might be a composite animal model for the study of psoriasis and dyslipideamia comorbidity.
    Xie X; Zhang L; Lin Y; Wang Y; Liu W; Li X; Li P
    J Dermatol Sci; 2017 Oct; 88(1):20-28. PubMed ID: 28579438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Keratinocyte proline-rich protein modulates immune and epidermal response in imiquimod-induced psoriatic skin inflammation.
    Matsuno A; Sumida H; Nakanishi H; Ikeyama Y; Ishii T; Omori I; Saito H; Iwasawa O; Sugimori A; Yoshizaki A; Katoh H; Ishikawa S; Sato S
    Exp Dermatol; 2023 Dec; 32(12):2121-2130. PubMed ID: 37926955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of fire needling on imiquimod induced psoriasis-like lesion and STAT3 pathway in mice].
    Feng F; Wang Y; Zhao JX; Di TT; Meng YJ; Chen ZX; Qi C; Hu XQ; Wang YZ; Li P
    Zhongguo Zhen Jiu; 2022 May; 42(5):541-8. PubMed ID: 35543945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-hydroxytryptophan attenuates imiquimod-induced psoriasiform dermatitis probably through inhibition of IL-17A production and keratinocyte activation.
    Hsu PY; Yang HJ; Yang TH; Su CC
    Exp Dermatol; 2018 Nov; 27(11):1273-1279. PubMed ID: 30221419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gentiopicroside-Loaded Chitosan Nanoparticles Inhibit TNF-α-Induced Proliferation and Inflammatory Response in HaCaT Keratinocytes and Ameliorate Imiquimod-Induced Dermatitis Lesions in Mice.
    Zhao K; Pu S; Sun L; Zhou D
    Int J Nanomedicine; 2023; 18():3781-3800. PubMed ID: 37457802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mild electrical stimulation with heat shock reduces inflammatory symptoms in the imiquimod-induced psoriasis mouse model.
    Tsurekawa Y; Morita M; Suico MA; Moriuchi M; Nakano Y; Piruzyan M; Takada M; Fukami S; Shuto T; Kai H
    Exp Dermatol; 2018 Oct; 27(10):1092-1097. PubMed ID: 29928760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knockdown of Bcl-3 alleviates psoriasis and dyslipidemia comorbidity by regulating Akt pathway.
    Li W; Yang W; Yang C
    Allergol Immunopathol (Madr); 2022; 50(6):115-121. PubMed ID: 36335454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved imiquimod-induced psoriasis like dermatitis using microneedles in mice.
    Liang L; Fei WM; Zhao ZQ; Hao YY; Zhang C; Cui Y; Guo XD
    Eur J Pharm Biopharm; 2021 Jul; 164():20-27. PubMed ID: 33895291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.
    Couderc E; Morel F; Levillain P; Buffière-Morgado A; Camus M; Paquier C; Bodet C; Jégou JF; Pohin M; Favot L; Garcia M; Huguier V; Mcheik J; Lacombe C; Yssel H; Guillet G; Bernard FX; Lecron JC
    PLoS One; 2017; 12(7):e0181486. PubMed ID: 28708859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides.
    Li HJ; Wu NL; Pu CM; Hsiao CY; Chang DC; Hung CF
    Sci Rep; 2020 Feb; 10(1):2932. PubMed ID: 32076123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice.
    OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J
    Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allicin ameliorates imiquimod-induced psoriasis-like skin inflammation via disturbing the interaction of keratinocytes with IL-17A.
    Zhang L; Ma X; Shi R; Zhang L; Zhao R; Duan R; Qin Y; Gao S; Li X; Duan J; Li J
    Br J Pharmacol; 2023 Mar; 180(5):628-646. PubMed ID: 36355777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baicalin Ameliorates Imiquimod-Induced Psoriasis-Like Inflammation in Mice.
    Hung CH; Wang CN; Cheng HH; Liao JW; Chen YT; Chao YW; Jiang JL; Lee CC
    Planta Med; 2018 Oct; 84(15):1110-1117. PubMed ID: 29763944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hesperidin inhibits keratinocyte proliferation and imiquimod-induced psoriasis-like dermatitis via the IRS-1/ERK1/2 pathway.
    Li X; Xie X; Zhang L; Meng Y; Li N; Wang M; Zhai C; Liu Z; Di T; Zhang L; Li P
    Life Sci; 2019 Feb; 219():311-321. PubMed ID: 30658103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adiponectin-derived pentapeptide ameliorates psoriasiform skin inflammation by suppressing IL-17 production in γδT cells.
    Suh JH; Lee Y; Ohn J; Kim EJ; Kim TG; Jo SJ; Kim SJ; Chung JH
    J Dermatol Sci; 2022 Apr; 106(1):45-52. PubMed ID: 35331618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice.
    Sun J; Zhao Y; Hu J
    PLoS One; 2013; 8(6):e67078. PubMed ID: 23825622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-38 overexpression in keratinocytes limits desquamation but does not affect the global severity of imiquimod-induced skin inflammation in mice.
    Huard A; Rodriguez E; Talabot-Ayer D; Weigert A; Palmer G
    Front Immunol; 2024; 15():1387921. PubMed ID: 39119344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33.
    Athari SK; Poirier E; Biton J; Semerano L; Hervé R; Raffaillac A; Lemeiter D; Herbelin A; Girard JP; Caux F; Boissier MC; Bessis N
    Arthritis Res Ther; 2016 Jun; 18(1):143. PubMed ID: 27317338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gasdermin E-mediated keratinocyte pyroptosis participates in the pathogenesis of psoriasis by promoting skin inflammation.
    Li Y; He Y; Yang F; Liang R; Xu W; Li Y; Cheng J; Liang B; Tang M; Shi X; Zhuang J; Luo M; Li L; Zhang R; Liu H; Jie H; Li X; Han X; Sun E; Zhai Z
    Br J Dermatol; 2024 Aug; 191(3):385-396. PubMed ID: 38655652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Notch-Hes1 Signaling Regulates IL-17A
    Wang Y; Li X; Xing X; Xue H; Qi R; Ji H; Ma L
    Mediators Inflamm; 2020; 2020():8297134. PubMed ID: 32454795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.